Steve Schonfeld’s Aethlon Medical AEMD Stock Holding History

Steve Schonfeld’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4	Closed	-$41K	–	1754
2020 Q4	$41K	Buy	+4	New	+$26.7K	﹤0.01%	1504

Other funds holding AEMD

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Steve Schonfeld's AEMD Position: Q1 2021 in Review

Steve Schonfeld sold out of Aethlon Medical (AEMD) in Q1 2021, closing a stake of 4 shares — an estimated $41K sold.

Steve Schonfeld first reported a position in AEMD in Q4 2020 and held it in 1 quarter. The position peaked at $41K in Q4 2020. 16 funds tracked by Wall St. Rank hold AEMD as of Q1 2021.

Steve Schonfeld reported no remaining Aethlon Medical position as of Q1 2021 after selling out during the quarter.
Steve Schonfeld sold 4 Aethlon Medical shares in Q1 2021, an estimated $41K.
Steve Schonfeld first reported a position in Aethlon Medical in Q4 2020 and held it in 1 quarter.
Steve Schonfeld's Aethlon Medical position peaked at $41K in Q4 2020.
16 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.